MicroRNA-330 Is an Oncogenic Factor in Glioblastoma Cells by Regulating SH3GL2 Gene

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Qu, Shengtao ^a   Yao, Yilong ^a   Shang, Chao ^a   Xue, Yixue ^a   Ma, Jun ^a   Li, Zhen ^a   Liu, Yunhui ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 330; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CYCLE PROGRESSION; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; GENE; GENE CONTROL; GENE FUNCTION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC REGULATION; GENETIC TRANSFECTION; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; ONCOGENE; SH3GL2 GENE; TUMOR GROWTH;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; APOPTOSIS; BASE SEQUENCE; BRAIN; BRAIN NEOPLASMS; CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; MICRORNAS;

EID: 84866708809     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046010     Document Type: Article

References (36)

1. Ohgaki H, (2009) Epidemiology of brain tumors. Methods Mol Biol 472: 323-342.
2. Li C, Feng Y, Coukos G, Zhang L, (2009) Therapeutic microRNA strategies in human cancer. AAPS J 11: 747-757.
3. Zhong X, Coukos G, Zhang L, (2012) miRNAs in human cancer. Methods Mol Biol 822: 295-306.
4. Stark A, Brennecke J, Bushati N, Russell RB, Cohen SM, (2005) Animal MicroRNAs confer robustness to gene expression and have a significant impact on 3′UTR evolution. Cell 123: 1133-1146.
5. Chan JA, Krichevsky AM, Kosik KS, (2005) MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65: 6029-6033.
6. Lu Z, Liu M, Stribinskis V, Klinge CM, Ramos KS, et al. (2008) MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene 27: 4373-4379.
7. Shi ZM, Wang J, Yan Z, You YP, Li CY, et al. (2012) MiR-128 inhibits tumor growth and angiogenesis by targeting p70S6K1. PLoS One 7: e32709.
8. Silber J, Jacobsen A, Ozawa T, Harinath G, Pedraza A, et al. (2012) miR-34a Repression in Proneural Malignant Gliomas Upregulates Expression of Its Target PDGFRA and Promotes Tumorigenesis. PLoS One 7: e33844.
9. Kefas B, Godlewski J, Comeau L, Li Y, Abounader R, et al. (2008) microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. Cancer Res 68: 3566-3572.
10. Weber MJ, (2005) New human and mouse microRNA genes found by homology search. FEBS J 272: 59-73.
11. Lee KH, Chen YL, Yeh SD, Hsiao M, Lin JT, et al. (2009) MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation. Oncogene 28: 3360-3370.
12. Giachino C, Lantelme E, Lanzetti L, Saccone S, Bella Valle G, et al. (1997) A novel SH3-containing human gene family preferentially expressed in the central nervous system. Genomics 41: 427-434.
13. Ringstad N, Nemoto Y, De Camilli P, (1997) The SH3p4/Sh3p8/SH3p13 protein family: binding partners for synaptojanin and dynamin via a Grb2-like Src homology3 domain. Proc Natl Acad Sci U S A 94: 8569-8574.
14. Shang C, Guo Y, Fu S, Fu W, Sun K, (2010) SH3GL2 gene participates in MEK-ERK signal pathway partly by regulating EGFR in the laryngeal carcinoma cell line Hep2. Med Sci Monit 16: BR168-173.
15. Shang C, Hong Y, Sang M, Xue YX, (2010) The expression of SH3GL2 gene in human brain glioma. Progress of Anatomical Sciences 16: 128-130.
16. Potter N, Karakoula A, Phipps KP, Harkness W, Hayward R, et al. (2008) Genomic deletions correlate with underexpression of novel candidate genes at six loci in pediatric pilocytic astrocytoma. Neoplasia 10: 757-772.
17. Reutens AT, Begley CG, (2002) Endophilin-1: a multifunctional protein. Int J Biochem Cell Biol 34: 1173-1177.
18. Osterberg L, Levan K, Partheen K, Delle U, Olsson B, et al. (2009) Potential predictive markers of chemotherapy resistance in stage III ovarian serous carcinomas. BMC Cancer 9: 368.
19. Sinha S, Chunder N, Mukherjee N, Alam N, Roy A, et al. (2008) Frequent deletion and methylation in SH3GL2 and CDKN2A loci are associated with early- and late-onset breast carcinoma. Ann Surg Oncol 15: 1070-1080.
20. Ghosh A, Ghosh S, Maiti GP, Sabbir MG, Alam N, et al. (2009) SH3GL2 and CDKN2A/2B loci are independently altered in early dysplastic lesions of head and neck: correlation with HPV infection and tobacco habit. J Pathol 217: 408-419.
21. Nimmo RA, Slack FJ, (2009) An elegant miRror: microRNAs in stem cells, developmental timing and cancer. Chromosoma 118: 405-418.
22. Calin GA, Croce CM, (2006) MicroRNA-cancer connection: the beginning of a new tale. Cancer Res 66: 7390-7394.
23. Dalmay T, Edwards DR, (2006) MicroRNAs and the hallmarks of cancer. Oncogene 25: 6170-6175.
24. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
25. Esquela-Kerscher A, Slack FJ, (2006) Oncomirs- microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269.
26. Esteller M, (2011) Non-coding RNAs in human disease. Nat Rev Genet 12: 861-874.
27. Chen CZ, (2005) MicroRNAs as oncogenes and tumor suppressors. New England Journal of Medicine 353: 1768-1771.
28. Silber J, Jacobsen A, Ozawa T, Harinath G, Pedraza A, et al. (2012) miR-34a Repression in Proneural Malignant Gliomas Upregulates Expression of Its Target PDGFRA and Promotes Tumorigenesis. PLoS One 7: e33844.
29. Mercatelli N, Coppola V, Bonci D, Miele F, Costantini A, et al. (2008) The inhibition of the highly expressed miR-221 and miR-222 impairs the growth of prostate carcinoma xenografts in mice. PLoS One 3: e4029.
30. Howard L, Nelson KK, Maciewicz RA, Blobel CP, (1999) Interaction of the metalloprotease disintegrins MDC9 and MDC15 with two SH3 domain-containing proteins, endophilin I and SH3PX1. J Biol Chem 274: 31693-31699.
31. Petrelli A, Gilestro GF, Lanzardo S, Comoglio PM, Migone N, et al. (2002) The endophilin-CIN85-Cbl complex mediates ligand-dependent downregulation of c-Met. Nature 416: 187-190.
32. Wells A, (1999) EGF receptor. Int J Biochem Cell Biol 31: 637-643.
33. Song JY, Lee SW, Hong JP, Chang SE, Choe H, et al. (2009) Epidermal growth factor competes with EGF receptor inhibitors to induce cell death in EGFR-overexpressing tumor cells. Cancer Lett 283: 135-142.
34. Soubeyran P, Kowanetz K, Szymkiewicz I, Langdon WY, Dikic I, (2002) Cbl-CIN85-endophilin complex mediates ligand-induced downregulation of EGF receptors. Nature 416: 183-187.
35. Abdellatif M, (2012) Differential expression of microRNAs in different disease states. Circ Res 110: 638-650.
36. Hodzic J, Giovannetti E, Calvo BD, Adema AD, Peters GJ, (2011) Regulation of deoxycytidine kinase expression and sensitivity to gemcitabine by micro-RNA 330 and promoter methylation in cancer cells. Nucleosides Nucleotides Nucleic Acids 30: 1214-1222.